// App-Quantinova.ai

10114 : Comparison of treatment-related fatigue and tolerability between PD-1 immune checkpoint inhibitors and chemotherapy: A meta-analysis.

Researchers

Presenter

  • Tomohiro F. Nishijima

Principal Investigators

  • Shlomit S. Shachar

  • Hyman B. Muss

Medical Centers

  • Unv of North Carolina Lineberger Comp Cancer Ctr, Chapel Hill, NC

  • Rambam Health Care Campus, Haifa, Israel

  • University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC

Locations

  • United States

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Programmed cell death protein 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final